GlassScriptPhysician profile
Bridget M Whaley
NPI 1144671900
$18,253.88
in general payments reported to CMS, 2019-2025
14 companies · $5,451 in 2025
The $5,451 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $124 · 2021: $7,461 · 2022: $4,286 · 2023: $260 · 2024: $277 · 2025: $5,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $987.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $17,232.79 | 2020-2025 | Myday Contact Lens, Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $318.65 | 2019-2020 | |
| Astellas Pharma US INC | $121.60 | 2025 | Izervay |
| Abbvie INC. | $88.01 | 2022-2023 | Durysta |
| Avedro INC. | $77.13 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $70.55 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $66.69 | 2022-2024 | Infuse |
| Sun Pharmaceutical Industries INC. | $64.42 | 2020-2022 | |
| Harrow Eye, LLC | $52.93 | 2025 | Vevye |
| Genzyme Corporation | $50.00 | 2025 | |
| New World Medical,INC. | $44.87 | 2019 | |
| Oyster Point Pharma, INC. | $33.39 | 2024-2025 | Tyrvaya |
| Allergan, INC. | $20.35 | 2020 | |
| Alcon Vision LLC | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Whaley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.